Vsevolod Matveev

4.0k total citations · 2 hit papers
19 papers, 1.8k citations indexed

About

Vsevolod Matveev is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Vsevolod Matveev has authored 19 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Vsevolod Matveev's work include Prostate Cancer Treatment and Research (5 papers), Renal cell carcinoma treatment (3 papers) and Testicular diseases and treatments (3 papers). Vsevolod Matveev is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Renal cell carcinoma treatment (3 papers) and Testicular diseases and treatments (3 papers). Vsevolod Matveev collaborates with scholars based in Russia, France and Czechia. Vsevolod Matveev's co-authors include Hendrik Van Poppel, Richard Sylvester, Walter Albrecht, Thomas E. Keane, Laurence Klotz, L. Da Pozzo, A. Bono, Eila C. Skinner, Jean-Marie Maréchal and Sandrine Marréaud and has published in prestigious journals such as PLoS ONE, Annals of Oncology and European Urology.

In The Last Decade

Vsevolod Matveev

16 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Prospective Randomized EORTC Intergroup Phase 3 Study Comparing the Complications of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma

2006 764 citations Hendrik Van Poppel, L. Da Pozzo et al. European Urology profile →
A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma

2010 698 citations Hendrik Van Poppel, L. Da Pozzo et al. European Urology profile →

Peers

Countries citing papers authored by Vsevolod Matveev

Since Specialization

Citations

This map shows the geographic impact of Vsevolod Matveev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vsevolod Matveev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vsevolod Matveev more than expected).

Fields of papers citing papers by Vsevolod Matveev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vsevolod Matveev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vsevolod Matveev. The network helps show where Vsevolod Matveev may publish in the future.

Co-authorship network of co-authors of Vsevolod Matveev

This figure shows the co-authorship network connecting the top 25 collaborators of Vsevolod Matveev. A scholar is included among the top collaborators of Vsevolod Matveev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vsevolod Matveev. Vsevolod Matveev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	PRIORITI: Phase 4 study of triptorelin or active surveillance in high‐risk prostate cancer 2024 ·Asia-Pacific Journal of Clinical Oncology ·Vsevolod Matveev, Xin Gao, Evgeny Kopyltsov, Jindan Luo, Qiang Wei, Dingwei Ye, Fang-Jian Zhou, (unknown), Aude Houchard, Adnan Mahmood, Liping Xie	0
2	Real-World Outcomes in First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Prostate Cancer Registry 2020 ·Targeted Oncology ·Simon Chowdhury, Anders Bjartell, Nicolaas Lumen, Pablo Maroto, Thomas Paiss, F. Gómez-Veiga, Alison Birtle, Gero Kramer, Ewa Kalinka‐Warzocha, Dominique Spaëth, Susan Feyerabend, Vsevolod Matveev, Florence Lefresne, Martin Lukáč, Robert Wapenaar, Luís Costa	49
3	Dose-reduced first cycle of chemotherapy for prevention of life-threatening acute complications in nonseminomatous germ cell tumor patients with ultra high tumor markers and/or poor performance status 2018 ·Journal of Cancer Research and Clinical Oncology ·A. Tryakin, М. Yu. Fedyanin, (unknown), (unknown), (unknown), Vsevolod Matveev, (unknown), (unknown), (unknown), Sergei Tjulandin	7
4	Diagnosis and management of the growing teratoma syndrome: A single-center experience and review of the literature 2018 ·Urologic Oncology Seminars and Original Investigations ·Pia Paffenholz, David Pfister, Vsevolod Matveev, Axel Heidenreich	16
5	Clinical outcomes and testosterone levels following continuous androgen deprivation (CAD) in patients with relapsing or locally advanced prostate cancer (PC): A post hoc analysis of the ICELAND study 2016 ·Annals of Oncology ·Bertrand Tombal, Erik B. Cornel, Vsevolod Matveev, Teuvo L.J. Tammela, Jan Schraml, (unknown), Raj Persad, (unknown), (unknown), C. Schulman	1
6	Reduzierte Morbidität bei der Resektion von Residualtumoren nach Chemotherapie beim Seminom 2015 ·Der Urologe ·David Pfister, Daniel Porres, Vsevolod Matveev, Axel Heidenreich	6
7	Intermittent Versus Continuous Androgen Deprivation Therapy in Patients with Relapsing or Locally Advanced Prostate Cancer: A Phase 3b Randomised Study (ICELAND) 2015 ·European Urology ·Claude Schulman, Erik B. Cornel, Vsevolod Matveev, Teuvo L.J. Tammela, Jan Schraml, H. Bensadoun, (unknown), Raj Persad, (unknown), Francisco Gómez Veiga, Edwina Baskin-Bey, (unknown), Bertrand Tombal	33
8	Analysis of European Patients Enrolled in a Global Early Access Protocol with Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer Progressing After Chemotherapy 2014 ·Annals of Oncology ·Daniel Castellano, Sergio Bracarda, Marcello Tucci, Otakar Čapoun, Vsevolod Matveev, G. Bodoky, George Fountzilas, Gabriel Kacsó, Michael Borre, Iwona Skoneczna, Anil Londhe, Peter De Porre, D Atlan, Betty L. Goon, (unknown), (unknown), Vahid Naini, A. Molina, Cora N. Sternberg	1
9	Renal Cancer Risk and Occupational Exposure to Polycyclic Aromatic Hydrocarbons and Plastics 2011 ·Journal of Occupational and Environmental Medicine ·Sara Karami, Paolo Boffetta, Paul Brennan, Patricia A. Stewart, Давид Заридзе, Vsevolod Matveev, Vladimír Janout, Helena Kollárová, Vladimír Bencko, Marie Navrátilová, Neonila Szeszenia‐Dąbrowska, Dana Mateș, Jan Gromiec, (unknown), Wong‐Ho Chow, Nathaniel Rothman, Lee E. Moore	40
10	LINE-1 Methylation Levels in Leukocyte DNA and Risk of Renal Cell Cancer 2011 ·PLoS ONE ·Linda M. Liao, Paul Brennan, Dana M. van Bemmel, Давид Заридзе, Vsevolod Matveev, Vladimír Janout, Helena Kollárová, Vladimír Bencko, Marie Navrátilová, Neonila Szeszenia‐Dąbrowska, Dana Mateș, Nathaniel Rothman, Paolo Boffetta, Wong-Ho Chow, Lee E. Moore	52
11	Occupational exposure to arsenic, cadmium, chromium, lead and nickel, and renal cell carcinoma: a case–control study from Central and Eastern Europe 2011 ·Occupational and Environmental Medicine ·P. Boffetta, Luc Fontana, Patricia A. Stewart, David Zaridze, Neonilia Szeszenia‐Dabrowska, V. Janout, Vladimír Bencko, Lenka Foretová, Viorel Jinga, Vsevolod Matveev, Helena Kollárová, (unknown), Wong‐Ho Chow, (unknown), Dana van Bemmel, Sara Karami, Paul Brennan, Lee E. Moore	42
12	Can Lactase Persistence Genotype Be Used to Reassess the Relationship between Renal Cell Carcinoma and Milk Drinking? Potentials and Problems in the Application of Mendelian Randomization 2010 ·Cancer Epidemiology Biomarkers & Prevention ·Nicholas J. Timpson, Paul Brennan, Valérie Gaborieau, Lee E. Moore, Давид Заридзе, Vsevolod Matveev, Neonilia Szeszenia‐Dabrowska, Jolanta Lissowska, Dana Mateș, Vladimír Bencko, Lenka Foretová, Vladimír Janout, Wong‐Ho Chow, Nathaniel Rothman, Paolo Boffetta, Roger Harbord, George Davey Smith	17
13	A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma breakdown → 2010 ·European Urology ·Hendrik Van Poppel, L. Da Pozzo, Walter Albrecht, Vsevolod Matveev, A. Bono, (unknown), Marc Colombel, Laurence Klotz, Eila C. Skinner, Thomas E. Keane, Sandrine Marréaud, Sandra Collette, Richard Sylvester	698
14	Vitamin D Pathway Genes, Diet, and Risk of Renal Cell Carcinoma 2010 ·International Journal of Endocrinology ·Sara Karami, Paul Brennan, Marie Navrátilová, Dana Mateș, Давид Заридзе, Vladimír Janout, Helena Kollárová, Vladimír Bencko, Vsevolod Matveev, (unknown), Ivana Holcátová, Meredith Yeager, Stephen J. Chanock, Nathaniel Rothman, Paolo Boffetta, (unknown), Lee E. Moore	22
15	Analysis of SNPs and Haplotypes in Vitamin D Pathway Genes and Renal Cancer Risk 2009 ·PLoS ONE ·Sara Karami, Paul Brennan, Philip S. Rosenberg, Marie Navrátilová, Dana Mateș, Давид Заридзе, Vladimír Janout, Helena Kollárová, Vladimír Bencko, Vsevolod Matveev, Neonila Szeszenia‐Dąbrowska, Ivana Holcátová, Meredith Yeager, Stephen J. Chanock, Idan Menashe, Nathaniel Rothman, Wong-Ho Chow, Paolo Boffetta, Lee E. Moore	32
16	Biochip-based Test-system for Cancer Diagnostics. Simultaneous Quantitation of Total and Free Forms of Prostate-specific Antigen 2008 ·TechConnect Briefs ·A. Yu. Baryshnikov, (unknown), Vsevolod Matveev, (unknown), (unknown), (unknown), (unknown)	0
17	A Prospective Randomized EORTC Intergroup Phase 3 Study Comparing the Complications of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma breakdown → 2006 ·European Urology ·Hendrik Van Poppel, L. Da Pozzo, Walter Albrecht, Vsevolod Matveev, A. Bono, (unknown), Jean-Marie Maréchal, Laurence Klotz, Eila C. Skinner, Thomas E. Keane, (unknown), Richard Sylvester	764
18	280 Results of the randomized trial comparing radical and partial nephrectomy for small kidney neoplasms eortc protocol 30904 2004 ·European Urology Supplements ·Hendrik Van Poppel, P. Rigatti, W. Albrecht, Vsevolod Matveev, Aldo Bono, (unknown), (unknown), R. Sylvester	2
19	Surgical management of RCC with intrapericardiac IVC extension: diaphragmatic approach to the intrapericardiac IVC 2002 ·European Urology Supplements ·(unknown), Vsevolod Matveev, (unknown), (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact